Inhibition of protein misfolding and aggregation by natural phenolic compounds

[1]  Rahul,et al.  Protective Effect of Kaempferol on the Transgenic Drosophila Model of Alzheimer's Disease. , 2018, CNS & neurological disorders drug targets.

[2]  M. Bucciantini,et al.  Oleuropein aglycone stabilizes the monomeric α-synuclein and favours the growth of non-toxic aggregates , 2018, Scientific Reports.

[3]  J. Brender,et al.  A blend of two resveratrol derivatives abolishes hIAPP amyloid growth and membrane damage. , 2018, Biochimica et biophysica acta. Biomembranes.

[4]  Palak Patel,et al.  Inhibition of insulin amyloid fibrillation by Morin hydrate. , 2018, International journal of biological macromolecules.

[5]  C. Dyck.  Anti-Amyloid-β Monoclonal Antibodies for Alzheimer’s Disease: Pitfalls and Promise , 2018 .

[6]  Qiuchen Zheng,et al.  Mechanistic Studies of the Inhibition of Insulin Fibril Formation by Rosmarinic Acid. , 2018, Journal of Physical Chemistry B.

[7]  H. Fuchs,et al.  Epigallocatechin gallate (EGCG) reduces the intensity of pancreatic amyloid fibrils in human islet amyloid polypeptide (hIAPP) transgenic mice , 2018, Scientific Reports.

[8]  G. Bifulco,et al.  Down regulation of pro‐inflammatory pathways by tanshinone IIA and cryptotanshinone in a non‐genetic mouse model of Alzheimer's disease , 2017, Pharmacological research.

[9]  Xiaoyan Dong,et al.  Brazilin Inhibits Prostatic Acidic Phosphatase Fibrillogenesis and Decreases its Cytotoxicity. , 2017, Chemistry, an Asian journal.

[10]  Myeong Ok Kim,et al.  Neuroprotective Effect of Fisetin Against Amyloid-Beta-Induced Cognitive/Synaptic Dysfunction, Neuroinflammation, and Neurodegeneration in Adult Mice , 2017, Molecular Neurobiology.

[11]  J. Pantel,et al.  Impact of Resveratrol on Glucose Control, Hippocampal Structure and Connectivity, and Memory Performance in Patients with Mild Cognitive Impairment , 2017, Front. Neurosci..

[12]  Yu Zhang,et al.  Resveratrol ameliorates spatial learning memory impairment induced by Aβ1–42 in rats , 2017, Neuroscience.

[13]  A. Neves,et al.  Resveratrol and Grape Extract-loaded Solid Lipid Nanoparticles for the Treatment of Alzheimer’s Disease , 2017, Molecules.

[14]  R. He,et al.  Resveratrol Attenuates Formaldehyde Induced Hyperphosphorylation of Tau Protein and Cytotoxicity in N2a Cells , 2017, Frontiers in neuroscience.

[15]  Robert H. Brown,et al.  Decoding ALS: from genes to mechanism , 2016, Nature.

[16]  Claudio Soto,et al.  Molecular interaction between type 2 diabetes and Alzheimer’s disease through cross-seeding of protein misfolding , 2016, Molecular Psychiatry.

[17]  Wei Zhang,et al.  Morin reverses neuropathological and cognitive impairments in APPswe/PS1dE9 mice by targeting multiple pathogenic mechanisms , 2016, Neuropharmacology.

[18]  M. Ramazzotti,et al.  Mechanisms for the inhibition of amyloid aggregation by small ligands , 2016, Bioscience reports.

[19]  A. Lavecchia,et al.  The 37/67kDa laminin receptor (LR) inhibitor, NSC47924, affects 37/67kDa LR cell surface localization and interaction with the cellular prion protein , 2016, Scientific Reports.

[20]  Wei-Yun Wang,et al.  A Novel Multifunctional Compound Camellikaempferoside B Decreases Aβ Production, Interferes with Aβ Aggregation, and Prohibits Aβ-Mediated Neurotoxicity and Neuroinflammation. , 2016, ACS chemical neuroscience.

[21]  Jie Xu,et al.  Quercetin Protects against Okadaic Acid-Induced Injury via MAPK and PI3K/Akt/GSK3β Signaling Pathways in HT22 Hippocampal Neurons , 2016, PloS one.

[22]  M. Lee,et al.  Perilla frutescens var. japonica and rosmarinic acid improve amyloid-β25-35 induced impairment of cognition and memory function , 2016, Nutrition research and practice.

[23]  S. Doglia,et al.  The polyphenol Oleuropein aglycone hinders the growth of toxic transthyretin amyloid assemblies. , 2016, The Journal of nutritional biochemistry.

[24]  Yi Sun,et al.  Neuroprotective Effects of A Standardized Flavonoid Extract of Safflower Against Neurotoxin-Induced Cellular and Animal Models of Parkinson’s Disease , 2016, Scientific Reports.

[25]  Tara Pukala,et al.  Bioactive polyphenol interactions with β amyloid: a comparison of binding modelling, effects on fibril and aggregate formation and neuroprotective capacity. , 2016, Food & function.

[26]  M. C. Graber,et al.  Stabilization of α-Synuclein Fibril Clusters Prevents Fragmentation and Reduces Seeding Activity and Toxicity. , 2016, Biochemistry.

[27]  Kun Huang,et al.  Inhibition effects of tanshinone on the aggregation of α-synuclein. , 2016, Food & function.

[28]  Thomas P. Davis,et al.  Stabilizing Off-pathway Oligomers by Polyphenol Nanoassemblies for IAPP Aggregation Inhibition , 2016, Scientific Reports.

[29]  H. Zhao,et al.  Resveratrol decreases the insoluble Aβ1–42 level in hippocampus and protects the integrity of the blood–brain barrier in AD rats , 2015, Neuroscience.

[30]  C. Fierke,et al.  Inhibition of IAPP Aggregation and Toxicity by Natural Products and Derivatives , 2015, Journal of diabetes research.

[31]  B. Bano,et al.  Evaluation of polyphenols as possible therapeutics for amyloidoses: Comparative analysis of Kaempferol and Catechin. , 2015, International journal of biological macromolecules.

[32]  James B. Brewer,et al.  A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease , 2015, Neurology.

[33]  D. Del Rio,et al.  Transthyretin Binding Heterogeneity and Anti-amyloidogenic Activity of Natural Polyphenols and Their Metabolites* , 2015, The Journal of Biological Chemistry.

[34]  Duilio Cascio,et al.  Uncovering the Mechanism of Aggregation of Human Transthyretin , 2015, The Journal of Biological Chemistry.

[35]  Ling Yan,et al.  Resveratrol inhibits oligomeric Aβ-induced microglial activation via NADPH oxidase. , 2015, Molecular medicine reports.

[36]  T. Mohamed,et al.  Curcumin Binding to Beta Amyloid: A Computational Study , 2015, Chemical biology & drug design.

[37]  J. Keller,et al.  Oleocanthal Enhances Amyloid-β Clearance from the Brains of TgSwDI Mice and in Vitro across a Human Blood-Brain Barrier Model , 2015, ACS chemical neuroscience.

[38]  Sharmistha Banerjee,et al.  The beneficial role of curcumin on inflammation, diabetes and neurodegenerative disease: A recent update. , 2015, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[39]  A. Ghasemi,et al.  Inhibition of amyloid fibrillation and cytotoxicity of lysozyme fibrillation products by polyphenols. , 2015, International journal of biological macromolecules.

[40]  H. Nishijo,et al.  Phenolic compounds prevent the oligomerization of α‐synuclein and reduce synaptic toxicity , 2015, Journal of neurochemistry.

[41]  Amir S. Sharili,et al.  In Vitro Activity of Epigallocatechin Gallate and Quercetin Alone and in Combination versus Clinical Isolates of Methicillin-Resistant Staphylococcus aureus. , 2015, Journal of natural products.

[42]  Claudio Soto,et al.  Type 2 diabetes as a protein misfolding disease. , 2015, Trends in molecular medicine.

[43]  L. Leal,et al.  Neuroprotective Properties of the Standardized Extract from Camellia sinensis (Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson's Disease , 2015, Evidence-based complementary and alternative medicine : eCAM.

[44]  C. Meshul,et al.  Curcumin Treatment Improves Motor Behavior in α-Synuclein Transgenic Mice , 2015, PloS one.

[45]  E. Sigurdsson,et al.  Tau immunotherapy for Alzheimer's disease. , 2015, Trends in molecular medicine.

[46]  J. R. Ramírez-Pineda,et al.  The flavonoid quercetin ameliorates Alzheimer's disease pathology and protects cognitive and emotional function in aged triple transgenic Alzheimer's disease model mice , 2015, Neuropharmacology.

[47]  A. Surolia,et al.  Curcumin Pyrazole and its derivative (N-(3-Nitrophenylpyrazole) Curcumin inhibit aggregation, disrupt fibrils and modulate toxicity of Wild type and Mutant α-Synuclein , 2015, Scientific Reports.

[48]  M. Lotz,et al.  Transthyretin Deposition in Articular Cartilage: A Novel Mechanism in the Pathogenesis of Osteoarthritis , 2015, Arthritis & rheumatology.

[49]  Xi Zheng,et al.  Curcumin, Inflammation, and Chronic Diseases: How Are They Linked? , 2015, Molecules.

[50]  E. Wanker,et al.  Modulation of human IAPP fibrillation: cosolutes, crowders and chaperones. , 2015, Physical chemistry chemical physics : PCCP.

[51]  Thomas Wisniewski,et al.  Immunotherapeutic Approaches for Alzheimer’s Disease , 2015, Neuron.

[52]  D. Milardi,et al.  Resveratrol interferes with the aggregation of membrane-bound human-IAPP: a molecular dynamics study. , 2015, European journal of medicinal chemistry.

[53]  M. Stefani,et al.  Oleuropein aglycone protects against pyroglutamylated-3 amyloid-ß toxicity: biochemical, epigenetic and functional correlates , 2015, Neurobiology of Aging.

[54]  M. Fändrich,et al.  AA Amyloidosis : Pathogenesis and Targeted Therapy Gunilla , 2014 .

[55]  Shaoyi Jiang,et al.  Brazilin inhibits amyloid β-protein fibrillogenesis, remodels amyloid fibrils and reduces amyloid cytotoxicity , 2015, Scientific Reports.

[56]  Y. Sekijima.  Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments , 2015, Journal of Neurology, Neurosurgery & Psychiatry.

[57]  Huanxiang Liu,et al.  Molecular mechanism of the inhibition and remodeling of human islet amyloid polypeptide (hIAPP(1-37)) oligomer by resveratrol from molecular dynamics simulation. , 2015, The journal of physical chemistry. B.

[58]  E. Wanker,et al.  The green tea polyphenol (−)‐epigallocatechin gallate prevents the aggregation of tau protein into toxic oligomers at substoichiometric ratios , 2015, FEBS letters.

[59]  Y. Li,et al.  Quercetin protects human brain microvascular endothelial cells from fibrillar β-amyloid1–40-induced toxicity , 2015, Acta pharmaceutica Sinica. B.

[60]  S. Radford,et al.  Mutational Analysis of the Ability of Resveratrol To Inhibit Amyloid Formation by Islet Amyloid Polypeptide: Critical Evaluation of the Importance of Aromatic–Inhibitor and Histidine–Inhibitor Interactions , 2014, Biochemistry.

[61]  A. Segura‐Carretero,et al.  Pine Bark and Green Tea Concentrated Extracts: Antioxidant Activity and Comprehensive Characterization of Bioactive Compounds by HPLC–ESI-QTOF-MS , 2014, International journal of molecular sciences.

[62]  G. Shanmugam,et al.  Gallic acid, one of the components in many plant tissues, is a potential inhibitor for insulin amyloid fibril formation. , 2014, European journal of medicinal chemistry.

[63]  Gary W. Jones,et al.  Myricetin prevents fibrillogenesis of hen egg white lysozyme. , 2014, Journal of agricultural and food chemistry.

[64]  J. Carver,et al.  Gallic acid interacts with α-synuclein to prevent the structural collapse necessary for its aggregation. , 2014, Biochimica et biophysica acta.

[65]  W. Rosenblum.  Why Alzheimer trials fail: removing soluble oligomeric beta amyloid is essential, inconsistent, and difficult , 2014, Neurobiology of Aging.

[66]  Falaq Naz,et al.  Effect of Curcumin on Lifespan, Activity Pattern, Oxidative Stress, and Apoptosis in the Brains of Transgenic Drosophila Model of Parkinson's Disease , 2014, BioMed research international.

[67]  Li Yan,et al.  A simple high-performance liquid chromatographic method for the determination of brazilin and its application to a pharmacokinetic study in rats. , 2014, Journal of ethnopharmacology.

[68]  P. Maher,et al.  Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer’s disease transgenic mice , 2013, Aging cell.

[69]  Danielle M. Williams,et al.  Gallic acid is the major component of grape seed extract that inhibits amyloid fibril formation. , 2013, Bioorganic & medicinal chemistry letters.

[70]  C. Soto,et al.  Role of Protein Misfolding and Proteostasis Deficiency in Protein Misfolding Diseases and Aging , 2013, International journal of cell biology.

[71]  C. Park,et al.  Effects of brussels sprouts and their phytochemical components on oxidative stress-induced neuronal damages in PC12 cells and ICR mice. , 2013, Journal of medicinal food.

[72]  M. Stefani,et al.  Employing Alzheimer Disease Animal Models for Translational Research: Focus on Dietary Components , 2013, Neurodegenerative Diseases.

[73]  A. Pilarski,et al.  Hippocampal neurogenesis in Alzheimer's disease: is there a role for dietary modulation? , 2013, Journal of Alzheimer's disease : JAD.

[74]  R. Yazdanparast,et al.  Apigenin reduces human insulin fibrillation in vitro and protects SK-N-MC cells against insulin amyloids. , 2013, International journal of biological macromolecules.

[75]  C. Soto,et al.  Cross-Seeding of Misfolded Proteins: Implications for Etiology and Pathogenesis of Protein Misfolding Diseases , 2013, PLoS pathogens.

[76]  M. Stefani,et al.  The Polyphenol Oleuropein Aglycone Protects TgCRND8 Mice against Aß Plaque Pathology , 2013, PloS one.

[77]  Rui Liu,et al.  Neuroprotective, Anti-Amyloidogenic and Neurotrophic Effects of Apigenin in an Alzheimer’s Disease Mouse Model , 2013, Molecules.

[78]  Cheng-I Lee,et al.  Curcumin Reduces Amyloid Fibrillation of Prion Protein and Decreases Reactive Oxidative Stress , 2013, Pathogens.

[79]  A. Wen,et al.  Application of a liquid chromatography-tandem mass spectrometry method to the pharmacokinetics, tissue distribution and excretion studies of brazilin in rats. , 2013, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[80]  E. Masliah,et al.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies. , 2013, Pharmacology & therapeutics.

[81]  Qingqiang Yao,et al.  A validated LC-MS/MS method for rapid determination of brazilin in rat plasma and its application to a pharmacokinetic study. , 2013, Biomedical chromatography : BMC.

[82]  M. Taghizadeh,et al.  Iranian medicinal plants for diabetes mellitus: a systematic review. , 2013, Pakistan journal of biological sciences : PJBS.

[83]  Claudia Durán-Aniotz,et al.  [Amyloid aggregates: role in Protein Misfolding Disorders]. , 2013, Revista médica de Chile (Impresa).

[84]  Min Zhu,et al.  Oxidized quercetin inhibits α-synuclein fibrillization. , 2013, Biochimica et biophysica acta.

[85]  Jie Zheng,et al.  Tanshinones inhibit amyloid aggregation by amyloid-β peptide, disaggregate amyloid fibrils, and protect cultured cells. , 2013, ACS chemical neuroscience.

[86]  M. Stefani,et al.  Oleuropein Aglycone Protects Transgenic C. elegans Strains Expressing Aβ42 by Reducing Plaque Load and Motor Deficit , 2013, PloS one.

[87]  D. Moffet,et al.  IAPP aggregation and cellular toxicity are inhibited by 1,2,3,4,6-penta-O-galloyl-β-d-glucose , 2013, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[88]  G. Pasinetti,et al.  Identification of brain‐targeted bioactive dietary quercetin‐3‐O‐glucuronide as a novel intervention for Alzheimer's disease , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[89]  Jiang-Ning Zhou,et al.  The binding of resveratrol to monomer and fibril amyloid beta , 2012, Neurochemistry International.

[90]  A. Fallarero,et al.  Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine. , 2012, Bioorganic & Medicinal Chemistry.

[91]  Sung-Hoon Kim,et al.  Tanshinones: Sources, Pharmacokinetics and Anti-Cancer Activities , 2012, International journal of molecular sciences.

[92]  B. Hyman,et al.  The synaptic accumulation of hyperphosphorylated tau oligomers in Alzheimer disease is associated with dysfunction of the ubiquitin-proteasome system. , 2012, The American journal of pathology.

[93]  Justin A. Lemkul,et al.  Morin inhibits the early stages of amyloid β-peptide aggregation by altering tertiary and quaternary interactions to produce "off-pathway" structures. , 2012, Biochemistry.

[94]  S. Thuret,et al.  The Role of Dietary Polyphenols on Adult Hippocampal Neurogenesis: Molecular Mechanisms and Behavioural Effects on Depression and Anxiety , 2012, Oxidative medicine and cellular longevity.

[95]  D. Moffet,et al.  Myricetin Inhibits Islet Amyloid Polypeptide (IAPP) Aggregation and Rescues Living Mammalian Cells from IAPP Toxicity , 2012, The open biochemistry journal.

[96]  Samuel Sparks,et al.  Curcumin modulates the self-assembly of the islet amyloid polypeptide by disassembling α-helix. , 2012, Biochemical and biophysical research communications.

[97]  M. Saraiva,et al.  Natural polyphenols as modulators of TTR amyloidogenesis: in vitro and in vivo evidences towards therapy , 2012, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[98]  B. Caughey,et al.  Assessment of Prospective Preventive Therapies for Chronic Wasting Disease in Mule Deer , 2012, Journal of wildlife diseases.

[99]  D. Raleigh,et al.  Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols. , 2012, Biochemistry.

[100]  H. Nishijo,et al.  Phenolic compounds prevent beta-amyloid-protein oligomerization and synaptic dysfunction by site-specific binding , 2012, Alzheimer's & Dementia.

[101]  D. Raleigh,et al.  Morin hydrate inhibits amyloid formation by islet amyloid polypeptide and disaggregates amyloid fibers , 2012, Protein science : a publication of the Protein Society.

[102]  S. Tabrizi,et al.  Misfolded PrP and a novel mechanism of proteasome inhibition , 2012, Prion.

[103]  K. Lu,et al.  Resveratrol Protects Rats from Aβ-induced Neurotoxicity by the Reduction of iNOS Expression and Lipid Peroxidation , 2011, PloS one.

[104]  M. Bucciantini,et al.  Aβ(1-42) aggregates into non-toxic amyloid assemblies in the presence of the natural polyphenol oleuropein aglycon. , 2011, Current Alzheimer research.

[105]  Y. Mou,et al.  Cryptotanshinione Inhibits β-Amyloid Aggregation and Protects Damage from β-Amyloid in SH-SY5Y Cells , 2011, Neurochemical Research.

[106]  Antonia Gutierrez,et al.  Abnormal accumulation of autophagic vesicles correlates with axonal and synaptic pathology in young Alzheimer’s mice hippocampus , 2011, Acta Neuropathologica.

[107]  J. Terao,et al.  Accumulation of orally administered quercetin in brain tissue and its antioxidative effects in rats. , 2011, Free radical biology & medicine.

[108]  D. Mereles,et al.  Epigallocatechin-3-gallate (EGCG) for Clinical Trials: More Pitfalls than Promises? , 2011, International journal of molecular sciences.

[109]  M. Saraiva,et al.  Natural polyphenols inhibit different steps of the process of transthyretin (TTR) amyloid fibril formation , 2011, FEBS letters.

[110]  Claudio Soto,et al.  Misfolded protein aggregates: mechanisms, structures and potential for disease transmission. , 2011, Seminars in cell & developmental biology.

[111]  G. Lippens,et al.  Oleuropein and derivatives from olives as Tau aggregation inhibitors , 2011, Neurochemistry International.

[112]  Huijun Sun,et al.  Apigenin Isolated from the Medicinal Plant Elsholtzia rugulosa Prevents β-Amyloid 25–35-Induces Toxicity in Rat Cerebral Microvascular Endothelial Cells , 2011, Molecules.

[113]  A. Giese,et al.  Inhibition and disaggregation of α‐synuclein oligomers by natural polyphenolic compounds , 2011, FEBS letters.

[114]  J. Collinge,et al.  Rapid cell-surface prion protein conversion revealed using a novel cell system , 2011, Nature communications.

[115]  Joan-Emma Shea,et al.  Resveratrol inhibits the formation of multiple-layered β-sheet oligomers of the human islet amyloid polypeptide segment 22-27. , 2011, Biophysical journal.

[116]  Hong-Guang Jin,et al.  Biflavonoids are superior to monoflavonoids in inhibiting amyloid-β toxicity and fibrillogenesis via accumulation of nontoxic oligomer-like structures. , 2011, Biochemistry.

[117]  C. Ross,et al.  Huntington's disease: from molecular pathogenesis to clinical treatment , 2011, The Lancet Neurology.

[118]  D. Hinton,et al.  Protein Kinase C-Regulated Aβ Production and Clearance , 2011, International journal of Alzheimer's disease.

[119]  J. Purcell,et al.  ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease. , 2011, Human molecular genetics.

[120]  M. Chan-Park,et al.  The Molecular Basis of Distinct Aggregation Pathways of Islet Amyloid Polypeptide* , 2010, The Journal of Biological Chemistry.

[121]  R. Tsao.  Chemistry and Biochemistry of Dietary Polyphenols , 2010, Nutrients.

[122]  M. Clifford,et al.  Bioavailability of dietary flavonoids and phenolic compounds. , 2010, Molecular aspects of medicine.

[123]  J. Dordick,et al.  Aromatic Small Molecules Remodel Toxic Soluble Oligomers of Amyloid β through Three Independent Pathways* , 2010, The Journal of Biological Chemistry.

[124]  P. Butler,et al.  The effect of curcumin on human islet amyloid polypeptide misfolding and toxicity , 2010, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[125]  M. Bucciantini,et al.  Oleuropein aglycon prevents cytotoxic amyloid aggregation of human amylin. , 2010, Journal of Nutritional Biochemistry.

[126]  D. Westaway,et al.  Lysosomal Proteolysis and Autophagy Require Presenilin 1 and Are Disrupted by Alzheimer-Related PS1 Mutations , 2010, Cell.

[127]  J. Dordick,et al.  Resveratrol Selectively Remodels Soluble Oligomers and Fibrils of Amyloid Aβ into Off-pathway Conformers* , 2010, The Journal of Biological Chemistry.

[128]  K. Wada,et al.  Relationship between the tautomeric structures of curcumin derivatives and their Abeta-binding activities in the context of therapies for Alzheimer's disease. , 2010, Biomaterials.

[129]  D. Ehrnhoefer,et al.  EGCG remodels mature α-synuclein and amyloid-β fibrils and reduces cellular toxicity , 2010, Proceedings of the National Academy of Sciences.

[130]  Rodrigo Morales,et al.  Molecular Cross Talk between Misfolded Proteins in Animal Models of Alzheimer's and Prion Diseases , 2010, The Journal of Neuroscience.

[131]  M. D'Archivio,et al.  Bioavailability of the Polyphenols: Status and Controversies , 2010, International journal of molecular sciences.

[132]  H. Katus,et al.  Effects of the main green tea polyphenol epigallocatechin-3-gallate on cardiac involvement in patients with AL amyloidosis , 2010, Clinical Research in Cardiology.

[133]  Chang-Ju Kim,et al.  Protective Effects of Kaempferol (3,4′,5,7-tetrahydroxyflavone) against Amyloid Beta Peptide (Aβ)-Induced Neurotoxicity in ICR Mice , 2010, Bioscience, biotechnology, and biochemistry.

[134]  A. Murase,et al.  Phenolic compounds prevent Alzheimer's pathology through different effects on the amyloid-beta aggregation pathway. , 2009, The American journal of pathology.

[135]  Lei Huang,et al.  Resveratrol inhibits beta-amyloid oligomeric cytotoxicity but does not prevent oligomer formation. , 2009, Neurotoxicology.

[136]  W. Klein,et al.  Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal. , 2009, Toxicology and applied pharmacology.

[137]  Jeffrey B. Sperry,et al.  Inhibition of tau fibrillization by oleocanthal via reaction with the amino groups of tau , 2009, Journal of neurochemistry.

[138]  S. Maeda,et al.  A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6‐penta‐O‐galloyl‐β‐d‐glucopyranose have potent anti‐aggregation effects on Alzheimer’s amyloid β proteins in vitro and in vivo , 2009, Journal of neurochemistry.

[139]  C. Zurzolo,et al.  Identification of an Intracellular Site of Prion Conversion , 2009, PLoS pathogens.

[140]  L Bravo,et al.  Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. , 2009, Nutrition reviews.

[141]  Marie-Claude Potier,et al.  Classification and basic pathology of Alzheimer disease , 2009, Acta Neuropathologica.

[142]  Roland Winter,et al.  Inhibiting Islet Amyloid Polypeptide Fibril Formation by the Red Wine Compound Resveratrol , 2009, Chembiochem : a European journal of chemical biology.

[143]  M. Beal,et al.  Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease , 2009, Neurochemistry International.

[144]  Kumiko Sakai-Kato,et al.  Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid β protein , 2008, Neuroscience Letters.

[145]  R. Nixon,et al.  Neurodegenerative lysosomal disorders: A continuum from development to late age , 2008, Autophagy.

[146]  D. Ehrnhoefer,et al.  EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers , 2008, Nature Structural &Molecular Biology.

[147]  Iva Hafner-Bratkovič,et al.  Curcumin binds to the α‐helical intermediate and to the amyloid form of prion protein – a new mechanism for the inhibition of PrPSc accumulation , 2008 .

[148]  V. Mok,et al.  Six-month randomized, placebo-controlled, double-blind, pilot clinical trial of curcumin in patients with Alzheimer disease. , 2008, Journal of clinical psychopharmacology.

[149]  William C. Nolan,et al.  Curcumin inhibits aggregation of α-synuclein , 2008, Acta Neuropathologica.

[150]  Fabrizio Chiti,et al.  Prevention of amyloid‐like aggregation as a driving force of protein evolution , 2007, EMBO reports.

[151]  R. Kayed,et al.  Small Molecule Inhibitors of Aggregation Indicate That Amyloid β Oligomerization and Fibrillization Pathways Are Independent and Distinct* , 2007, Journal of Biological Chemistry.

[152]  Susan Lindquist,et al.  Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. , 2006, Human molecular genetics.

[153]  L. Estrada,et al.  Inhibition of protein misfolding and aggregation by small rationally-designed peptides. , 2006, Current pharmaceutical design.

[154]  Angelo A. Izzo,et al.  The Spice Sage and Its Active Ingredient Rosmarinic Acid Protect PC12 Cells from Amyloid-β Peptide-Induced Neurotoxicity , 2006, Journal of Pharmacology and Experimental Therapeutics.

[155]  Kenjiro Ono,et al.  Antioxidant compounds have potent anti‐fibrillogenic and fibril‐destabilizing effects for α‐synuclein fibrils in vitro , 2006, Journal of neurochemistry.

[156]  Claudio Soto,et al.  Amyloids, prions and the inherent infectious nature of misfolded protein aggregates. , 2006, Trends in biochemical sciences.

[157]  B. Caughey,et al.  Comparison of protease-resistant prion protein inhibitors in cell cultures infected with two strains of mouse and sheep scrapie , 2005, Neuroscience Letters.

[158]  Peter Davies,et al.  Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides* , 2005, Journal of Biological Chemistry.

[159]  Byeoung-Soo Park,et al.  Effects of naturally occurring compounds on fibril formation and oxidative stress of beta-amyloid. , 2005, Journal of agricultural and food chemistry.

[160]  Robert A. Grothe,et al.  Structure of the cross-β spine of amyloid-like fibrils , 2005, Nature.

[161]  Christian Néri,et al.  Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons , 2005, Nature Genetics.

[162]  Takeshi Iwatsubo,et al.  Inhibition of Heparin-induced Tau Filament Formation by Phenothiazines, Polyphenols, and Porphyrins* , 2005, Journal of Biological Chemistry.

[163]  Fusheng Yang,et al.  Curcumin Inhibits Formation of Amyloid β Oligomers and Fibrils, Binds Plaques, and Reduces Amyloid in Vivo* , 2005, Journal of Biological Chemistry.

[164]  M. Stefani.  Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. , 2004, Biochimica et biophysica acta.

[165]  K. Ono,et al.  Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro. , 2004, Biochimica et biophysica acta.

[166]  J. Nutt,et al.  Parkinson's disease , 2004, The Lancet.

[167]  M. Lean,et al.  HPLC-MSn analysis of phenolic compounds and purine alkaloids in green and black tea. , 2004, Journal of agricultural and food chemistry.

[168]  Kenjiro Ono,et al.  Curcumin has potent anti‐amyloidogenic effects for Alzheimer's β‐amyloid fibrils in vitro , 2004, Journal of neuroscience research.

[169]  B. Caughey,et al.  New Inhibitors of Scrapie-Associated Prion Protein Formation in a Library of 2,000 Drugs and Natural Products , 2003, Journal of Virology.

[170]  Peter Bross,et al.  Protein misfolding and disease : principles and protocols , 2003 .

[171]  G. J. Raymond,et al.  Inhibition of Protease-Resistant Prion Protein Accumulation In Vitro by Curcumin , 2003, Journal of Virology.

[172]  Peter K. T. Pang,et al.  The establishment of a reliable cytotoxic system with SK-N-SH neuroblastoma cell culture , 2003, Journal of Neuroscience Methods.

[173]  C. Soto,et al.  Protein misfolding and disease; protein refolding and therapy , 2001, FEBS letters.

[174]  Wenhua Zheng,et al.  Effects of amyloid peptides on cell viability and expression of neuropeptides in cultured rat dorsal root ganglion neurons: a role for free radicals and protein kinase C , 2001, The European journal of neuroscience.

[175]  James C. Sacchettini,et al.  Rational design of potent human transthyretin amyloid disease inhibitors , 2000, Nature Structural Biology.

[176]  C. Dobson.  Protein misfolding, evolution and disease. , 1999, Trends in biochemical sciences.

[177]  W. Schaffner,et al.  Phytoestrogen kaempferol (3,4′,5,7‐tetrahydroxyflavone) protects PC12 and T47D cells from β‐amyloid–induced toxicity , 1999, Journal of neuroscience research.

[178]  Claudio Soto,et al.  β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy , 1998, Nature Medicine.

[179]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[180]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[181]  J. Herbert,et al.  Chelerythrine is a potent and specific inhibitor of protein kinase C. , 1990, Biochemical and biophysical research communications.

[182]  K. Ono,et al.  Natural Phenolic Compounds as Therapeutic and Preventive Agents for Cerebral Amyloidosis. , 2015, Advances in experimental medicine and biology.

[183]  J. del Valle,et al.  Neuroprotective role of trans-resveratrol in a murine model of familial Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.

[184]  M. Saraiva,et al.  Dietary curcumin counteracts extracellular transthyretin deposition: insights on the mechanism of amyloid inhibition. , 2013, Biochimica et biophysica acta.

[185]  E. Tsilibary,et al.  Oleuropein, an Anti-oxidant Polyphenol Constituent of Olive Promotes α-Secretase Cleavage of the Amyloid Precursor Protein (AβPP) , 2012, Cellular and Molecular Neurobiology.

[186]  Michael R. Schmidt,et al.  Small-molecule conversion of toxic oligomers to nontoxic β-sheet-rich amyloid fibrils. , 2011, Nature chemical biology.

[187]  K. Markides,et al.  Study of the interaction between the amyloid beta peptide (1-40) and antioxidant compounds by nuclear magnetic resonance spectroscopy. , 2011, Biopolymers.

[188]  Masaki Wakabayashi,et al.  Inhibitors of amyloid beta-protein aggregation mediated by GM1-containing raft-like membranes. , 2007, Biochimica et biophysica acta.

[189]  C. Hetz,et al.  Protein misfolding and disease: the case of prion disorders , 2003, Cellular and Molecular Life Sciences CMLS.

[190]  Claudio Soto,et al.  Unfolding the role of protein misfolding in neurodegenerative diseases , 2003, Nature Reviews Neuroscience.